NO991096D0 - Nye fremgangsmÕter - Google Patents

Nye fremgangsmÕter

Info

Publication number
NO991096D0
NO991096D0 NO991096A NO991096A NO991096D0 NO 991096 D0 NO991096 D0 NO 991096D0 NO 991096 A NO991096 A NO 991096A NO 991096 A NO991096 A NO 991096A NO 991096 D0 NO991096 D0 NO 991096D0
Authority
NO
Norway
Prior art keywords
new procedures
procedures
new
Prior art date
Application number
NO991096A
Other languages
English (en)
Other versions
NO991096L (no
Inventor
Jeremy N Radbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO991096L publication Critical patent/NO991096L/no
Publication of NO991096D0 publication Critical patent/NO991096D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO991096A 1996-09-06 1999-03-05 Nye fremgangsmÕter NO991096D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24
PCT/US1997/015475 WO1998009619A1 (en) 1996-09-06 1997-09-03 Novel methods

Publications (2)

Publication Number Publication Date
NO991096L NO991096L (no) 1999-03-05
NO991096D0 true NO991096D0 (no) 1999-03-05

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
NO991096A NO991096D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter
NO991097A NO991097D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO991097A NO991097D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter

Country Status (16)

Country Link
EP (2) EP0929216A4 (no)
JP (2) JP2002515047A (no)
KR (2) KR20000068473A (no)
CN (2) CN1236313A (no)
AR (1) AR008155A1 (no)
AU (2) AU4247397A (no)
BR (2) BR9711676A (no)
CA (2) CA2264943A1 (no)
CO (2) CO5070658A1 (no)
CZ (1) CZ76699A3 (no)
IL (1) IL128645A0 (no)
NO (2) NO991096D0 (no)
PL (2) PL332278A1 (no)
TR (2) TR199900506T2 (no)
TW (1) TW411273B (no)
WO (2) WO1998009619A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (en) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3762617D1 (de) * 1986-09-11 1990-06-13 Nat Res Dev Tamoxifenderivate.
CA2143000C (en) * 1992-09-15 2000-03-28 Alan J. Bitonti Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
ATE377418T1 (de) * 1995-06-07 2007-11-15 Poniard Pharmaceuticals Inc Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
EP0929216A4 (en) 2001-04-04
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
AR008155A1 (es) 1999-12-09
CO4920218A1 (es) 2000-05-29
WO1998009519A1 (en) 1998-03-12
JP2002515047A (ja) 2002-05-21
JP2002515046A (ja) 2002-05-21
TR199900506T2 (xx) 1999-07-21
CA2264775A1 (en) 1998-03-12
AU4247397A (en) 1998-03-26
TR199900504T2 (xx) 1999-06-21
NO991096L (no) 1999-03-05
BR9711676A (pt) 1999-08-24
CN1236299A (zh) 1999-11-24
CO5070658A1 (es) 2001-08-28
EP0929216A1 (en) 1999-07-21
PL332278A1 (en) 1999-08-30
EP0927029A4 (en) 2001-06-13
TW411273B (en) 2000-11-11
CZ76699A3 (cs) 1999-08-11
KR20000068472A (ko) 2000-11-25
CN1236313A (zh) 1999-11-24
CA2264943A1 (en) 1998-03-12
KR20000068473A (ko) 2000-11-25
NO991097L (no) 1999-03-05
NO991097D0 (no) 1999-03-05
IL128645A0 (en) 2000-01-31
PL332038A1 (en) 1999-08-16
EP0927029A1 (en) 1999-07-07
WO1998009619A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
NO970512D0 (no) Nye heteroaryl-oksazolidinoner
NO970374L (no) Nye forbindelser
NO983356D0 (no) Nye 19-nor-pregnenderivater
NO20000312L (no) Nye forbindelser
NO970511D0 (no) Nye substituerte oksazolidinoner
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20002787D0 (no) Nye forbindelser
DK0906288T3 (da) Nye forbindelser
DK0770132T3 (da) Nye streptograminer
NO960268D0 (no) Nye dialkoksypyridinylbenzimidazolderivater
DE59708449D1 (de) Substituierte p-trifluormethylphenyluracile
NO971711D0 (no) Nye retinoider
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
NO991096D0 (no) Nye fremgangsmÕter
ATE275146T1 (de) Substituierte pyrazol-3-ylbenzazole
DE29716570U1 (de) Achsen-Vorrichtung
NO990072D0 (no) Nye forbindelser
DE29619891U1 (de) Siebrechen
BR9708893A (pt) Ferniluracilas substituidas
NO983505D0 (no) Nye fenantrider
DE59708674D1 (de) Substituierte 3-phenylpyrazole
DE59712222D1 (de) Substituierte phenyluracile
DE29604675U1 (de) Kopfbedeckung
DE59701309D1 (de) Kopfbedeckung
DE29610036U1 (de) Kopfbedeckung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application